Statins and Ezetimibe
Pre-clinicalUNKNOWN 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Heterozigous Familial Hypercholesterolemia
Conditions
Heterozigous Familial Hypercholesterolemia
Trial Timeline
Apr 1, 2007 → —
NCT ID
NCT00475826About Statins and Ezetimibe
Statins and Ezetimibe is a pre-clinical stage product being developed by Merck for Heterozigous Familial Hypercholesterolemia. The current trial status is unknown. This product is registered under clinical trial identifier NCT00475826. Target conditions include Heterozigous Familial Hypercholesterolemia.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00475826 | Pre-clinical | UNKNOWN |